open access

Vol 8, No 1 (2005)
Published online: 2005-06-21
Submitted: 2012-01-23
Get Citation

Uptake of radiolabelled endomorphins by experimental mammary adenocarcinoma

Rafał Wiercioch, Marek Mirowski, Ewa Balcerczak, Ewa Byszewska, Ryszard Wierzbicki
Nucl. Med. Rev 2005;8(1):1-6.

open access

Vol 8, No 1 (2005)
Published online: 2005-06-21
Submitted: 2012-01-23

Abstract

BACKGROUND: The aim of this study was to examine the accumulation of endomorphin-1 (Tyr-Pro-Trp-Phe-NH2) and endomorphin- 2 (Tyr-Pro-Phe-Phe-NH2) labelled with radioiodine in tumour-bearing C3H/Bi mice.
MATERIAL AND METHODS: Mice C3H/Bi bearing transplantable mammary adenocarcinoma were used as animal models to study the interaction between µ-opioid receptors and endomorphin-1 and 2. The expression of the µ-opioid receptor in the tumours was confirmed by cross-linking assay and by RT- PCR technique.
RESULTS: The endomorphins showed relatively high tumour accumulation — about 5.2% of dose/g tissue for endomorphin-1 and about 3.8% for endomorphin-2. The ratio of tumour to muscle for endomorphin-2 reached the highest value (12.7) six hours after injection. For endomorhin-1 this ratio was the highest (7.5) three hours after injection. The cross-linking assay of [125I]-labelled peptides with membranes, isolated from the mouse adenocarcinoma, followed by electrophoresis and autoradiography revealed the presence of a radioactive complex with molecular weight of about 65 kDa. This complex was detectable by polyclonal antibodies raised against the N-terminal end of a µ-opioid receptor. The expression of gene encoding µ-opioid receptor on mouse mammary adenocarcinoma was further confirmed by RT-PCR technique. The binding studies with membranes of mouse mammary adenocarcinoma cells have shown significantly higher Bmax values for endomorphin-1 and endomorphin- 2 (806 and 671, respectively) than for morphiceptin (131), a well-known specific µ-opioid receptor ligand.
CONCLUSIONS: Endomorphin-1 and 2 have shown a high affinity to the m-opioid receptor present in mouse mammary adenocarcinoma. However, endomorphin-2 showed more promising characteristics in biodistribution studies.

Abstract

BACKGROUND: The aim of this study was to examine the accumulation of endomorphin-1 (Tyr-Pro-Trp-Phe-NH2) and endomorphin- 2 (Tyr-Pro-Phe-Phe-NH2) labelled with radioiodine in tumour-bearing C3H/Bi mice.
MATERIAL AND METHODS: Mice C3H/Bi bearing transplantable mammary adenocarcinoma were used as animal models to study the interaction between µ-opioid receptors and endomorphin-1 and 2. The expression of the µ-opioid receptor in the tumours was confirmed by cross-linking assay and by RT- PCR technique.
RESULTS: The endomorphins showed relatively high tumour accumulation — about 5.2% of dose/g tissue for endomorphin-1 and about 3.8% for endomorphin-2. The ratio of tumour to muscle for endomorphin-2 reached the highest value (12.7) six hours after injection. For endomorhin-1 this ratio was the highest (7.5) three hours after injection. The cross-linking assay of [125I]-labelled peptides with membranes, isolated from the mouse adenocarcinoma, followed by electrophoresis and autoradiography revealed the presence of a radioactive complex with molecular weight of about 65 kDa. This complex was detectable by polyclonal antibodies raised against the N-terminal end of a µ-opioid receptor. The expression of gene encoding µ-opioid receptor on mouse mammary adenocarcinoma was further confirmed by RT-PCR technique. The binding studies with membranes of mouse mammary adenocarcinoma cells have shown significantly higher Bmax values for endomorphin-1 and endomorphin- 2 (806 and 671, respectively) than for morphiceptin (131), a well-known specific µ-opioid receptor ligand.
CONCLUSIONS: Endomorphin-1 and 2 have shown a high affinity to the m-opioid receptor present in mouse mammary adenocarcinoma. However, endomorphin-2 showed more promising characteristics in biodistribution studies.
Get Citation

Keywords

-opioid receptor; endomorphin-1; endomorphin-2; mouse mammary adenocarcinoma

About this article
Title

Uptake of radiolabelled endomorphins by experimental mammary adenocarcinoma

Journal

Nuclear Medicine Review

Issue

Vol 8, No 1 (2005)

Pages

1-6

Published online

2005-06-21

Bibliographic record

Nucl. Med. Rev 2005;8(1):1-6.

Keywords

-opioid receptor
endomorphin-1
endomorphin-2
mouse mammary adenocarcinoma

Authors

Rafał Wiercioch
Marek Mirowski
Ewa Balcerczak
Ewa Byszewska
Ryszard Wierzbicki

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl